Literature DB >> 21850538

[Urinary tract infections].

W H Hörl1.   

Abstract

Urinary tract infections occur very frequently in the community and in hospitalized patients and are mainly caused by Escherichia (E.) coli. Depending on virulence determinants of uropathogenic microorganisms and host-specific defense mechanisms, urinary tract infections can manifest as cystitis, pyelonephritis (bacterial interstitial nephritis), bacteremia or urosepsis. Uncomplicated urinary tract infections in otherwise healthy women should be treated for 3-7 days depending on the antibiotic therapy chosen, even if spontaneous remission rates of up to 40% have been reported. Antibiotics of the first choice for empirical treatment of uncomplicated urinary tract infection are fluoroquinolones, pivmecillinam and fosfomycin. A huge problem is the increasing antimicrobial resistance of uropathogenic microorganisms. Complicated urinary tract infections associated with anatomical and/or functional abnormalities of the urinary tract and/or comorbidities such as diabetes or immunosuppressive therapy, need longer antibiotic treatment (e.g. 10-14 days) as well as interdisciplinary diagnostic procedures. Treatment of community acquired urosepsis includes cephalosporins of the third generation, piperacillin/tazobactam or ciprofloxacin. For nosocomial urosepsis the combination with an aminoglycoside or a carbapenem is recommended.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21850538     DOI: 10.1007/s00108-011-2861-0

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  17 in total

Review 1.  The diagnosis of urinary tract infection: a systematic review.

Authors:  Guido Schmiemann; Eberhardt Kniehl; Klaus Gebhardt; Martha M Matejczyk; Eva Hummers-Pradier
Journal:  Dtsch Arztebl Int       Date:  2010-05-28       Impact factor: 5.594

2.  Symptomatic treatment (ibuprofen) or antibiotics (ciprofloxacin) for uncomplicated urinary tract infection?--results of a randomized controlled pilot trial.

Authors:  Jutta Bleidorn; Ildikó Gágyor; Michael M Kochen; Karl Wegscheider; Eva Hummers-Pradier
Journal:  BMC Med       Date:  2010-05-26       Impact factor: 8.775

3.  Tamm-Horsfall glycoprotein links innate immune cell activation with adaptive immunity via a Toll-like receptor-4-dependent mechanism.

Authors:  Marcus D Säemann; Thomas Weichhart; Maximilian Zeyda; Günther Staffler; Michael Schunn; Karl M Stuhlmeier; Yuri Sobanov; Thomas M Stulnig; Shizuo Akira; Alexander von Gabain; Uwe von Ahsen; Walter H Hörl; Gerhard J Zlabinger
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

Review 4.  [National S3 guideline on uncomplicated urinary tract infection: recommendations for treatment and management of uncomplicated community-acquired bacterial urinary tract infections in adult patients].

Authors:  F M E Wagenlehner; G Schmiemann; U Hoyme; R Fünfstück; E Hummers-Pradier; M Kaase; E Kniehl; I Selbach; U Sester; W Vahlensieck; D Watermann; K G Naber
Journal:  Urologe A       Date:  2011-02       Impact factor: 0.639

5.  Cutting edge: Tlr5-/- mice are more susceptible to Escherichia coli urinary tract infection.

Authors:  Erica Andersen-Nissen; Thomas R Hawn; Kelly D Smith; Alex Nachman; Aaron E Lampano; Satoshi Uematsu; Shizuo Akira; Alan Aderem
Journal:  J Immunol       Date:  2007-04-15       Impact factor: 5.422

6.  Antimicrobial resistance in urinary tract pathogens in Canada from 2007 to 2009: CANWARD surveillance study.

Authors:  James A Karlowsky; Philippe R S Lagacé-Wiens; Patricia J Simner; Melanie R DeCorby; Heather J Adam; Andrew Walkty; Daryl J Hoban; George G Zhanel
Journal:  Antimicrob Agents Chemother       Date:  2011-05-02       Impact factor: 5.191

7.  Clinical and bacteriological outcome of different doses and duration of pivmecillinam compared with placebo therapy of uncomplicated lower urinary tract infection in women: the LUTIW project.

Authors:  Sven A Ferry; Stig E Holm; Hans Stenlund; Rolf Lundholm; Tor J Monsen
Journal:  Scand J Prim Health Care       Date:  2007-03       Impact factor: 2.581

8.  Randomised controlled trial of nitrofurantoin versus placebo in the treatment of uncomplicated urinary tract infection in adult women.

Authors:  T C M Christiaens; M De Meyere; G Verschraegen; W Peersman; S Heytens; J M De Maeseneer
Journal:  Br J Gen Pract       Date:  2002-09       Impact factor: 5.386

Review 9.  Dipsticks and diagnostic algorithms in urinary tract infection: development and validation, randomised trial, economic analysis, observational cohort and qualitative study.

Authors:  P Little; S Turner; K Rumsby; G Warner; M Moore; J A Lowes; H Smith; C Hawke; D Turner; G M Leydon; A Arscott; M Mullee
Journal:  Health Technol Assess       Date:  2009-03       Impact factor: 4.014

Review 10.  Antibiotics versus placebo in the treatment of women with uncomplicated cystitis: a meta-analysis of randomized controlled trials.

Authors:  Matthew E Falagas; Ioannis K Kotsantis; Evridiki K Vouloumanou; Petros I Rafailidis
Journal:  J Infect       Date:  2009-02-04       Impact factor: 6.072

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.